Maxcyte Inc (MXCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 7,300 | 6,829 | 8,507 | 10,390 | 8,692 |
| Cost of Goods | 1,610 | 1,596 | 1,519 | 1,497 | 2,281 |
| Gross Profit | 5,690 | 5,233 | 6,988 | 8,893 | 6,411 |
| Operating Expenses | 17,526 | 19,978 | 21,734 | 21,685 | 19,593 |
| Operating Income | -11,226 | -14,149 | -14,227 | -12,295 | -12,901 |
| Other Income | 1,630 | 1,733 | 1,870 | 2,034 | 2,304 |
| Pre-tax Income | -9,596 | -12,416 | -12,357 | -10,261 | -10,597 |
| Net Income Continuous | -9,596 | -12,416 | -12,357 | -10,261 | -10,597 |
| Net Income | $-9,596 | $-12,416 | $-12,357 | $-10,261 | $-10,597 |
| EPS Basic Total Ops | -0.08 | -0.12 | -0.12 | -0.10 | -0.10 |
| EPS Basic Continuous Ops | -0.09 | -0.12 | -0.12 | -0.10 | -0.10 |
| EPS Diluted Total Ops | -0.08 | -0.12 | -0.12 | -0.10 | -0.10 |
| EPS Diluted Continuous Ops | -0.09 | -0.12 | -0.12 | -0.10 | -0.10 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.12 | -0.12 | -0.10 | -0.10 |
| EBITDA(a) | $-7,027 | $-13,661 | $-13,878 | $-12,083 | $-13,034 |